| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 27,508 | 15,201 |
| Net increase (decrease) in cash and cash equivalents | 13,213 | 2,157 |
| Cash and cash equivalents at beginning of period | 76 | - |
| Cash and cash equivalents at end of period | 13,289 | - |
PLUS THERAPEUTICS, INC. (PSTV)
PLUS THERAPEUTICS, INC. (PSTV)